S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
NASDAQ:FLGT

Fulgent Genetics Stock Forecast, Price & News

$70.72
+1.65 (+2.39 %)
(As of 01/15/2021 08:00 PM ET)
Add
Compare
Today's Range
$66.30
Now: $70.72
$72.75
50-Day Range
$40.63
MA: $51.11
$70.84
52-Week Range
$6.70
Now: $70.72
$73.90
Volume52,419 shs
Average Volume2.64 million shs
Market Capitalization$1.72 billion
P/E Ratio35.01
Dividend YieldN/A
Beta1.92
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home Covid-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Fulgent Genetics logo

MarketRank

Overall MarketRank

1.24 out of 5 stars

Analyst Opinion: 1.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537
Employees473

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.53 million
Cash Flow$0.14 per share
Book Value$4.42 per share

Profitability

Net Income$-410,000.00

Miscellaneous

Market Cap$1.72 billion
Next Earnings Date3/9/2021 (Estimated)
OptionableNot Optionable
$70.72
+1.65 (+2.39 %)
(As of 01/15/2021 08:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

How has Fulgent Genetics' stock been impacted by Coronavirus?

Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FLGT shares have increased by 603.0% and is now trading at $70.72.
View which stocks have been most impacted by COVID-19
.

Is Fulgent Genetics a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Fulgent Genetics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FLGT, but not buy additional shares or sell existing shares.
View analyst ratings for Fulgent Genetics
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Fulgent Genetics?

Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for Fulgent Genetics
.

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics, Inc. (NASDAQ:FLGT) issued its quarterly earnings results on Monday, November, 9th. The company reported $2.08 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.39 by $1.69. The business earned $101.72 million during the quarter, compared to the consensus estimate of $51.73 million. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%.
View Fulgent Genetics' earnings history
.

What guidance has Fulgent Genetics issued on next quarter's earnings?

Fulgent Genetics updated its FY 2020 Pre-Market earnings guidance on Monday, November, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million.

What price target have analysts set for FLGT?

5 equities research analysts have issued 12 month price objectives for Fulgent Genetics' shares. Their forecasts range from $20.00 to $100.00. On average, they expect Fulgent Genetics' stock price to reach $55.40 in the next twelve months. This suggests that the stock has a possible downside of 21.7%.
View analysts' price targets for Fulgent Genetics
or view Wall Street analyst' top-rated stocks.

Who are some of Fulgent Genetics' key competitors?

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT).

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the following people:
  • Mr. Ming Hsieh, Chairman, CEO & Pres (Age 65, Pay $240k)
  • Mr. Paul Kim, Chief Financial Officer (Age 54, Pay $241.68k)
  • Dr. Han Lin Gao, Chief Scientific Officer & Laboratory Director (Age 54, Pay $216.3k)
  • Mr. Jian Xie, Chief Operating Officer (Age 55)
  • Mr. Brandon Perthuis, Chief Commercial Officer

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Raymond James Trust N.A. (1.39%), Crossmark Global Holdings Inc. (0.06%), New England Research & Management Inc. (0.06%), State of Alaska Department of Revenue (0.04%) and Louisiana State Employees Retirement System (0.02%). Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim.
View institutional ownership trends for Fulgent Genetics
.

Which institutional investors are selling Fulgent Genetics stock?

FLGT stock was sold by a variety of institutional investors in the last quarter, including Raymond James Trust N.A.. Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim.
View insider buying and selling activity for Fulgent Genetics
or view top insider-selling stocks.

Which institutional investors are buying Fulgent Genetics stock?

FLGT stock was purchased by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., New England Research & Management Inc., Louisiana State Employees Retirement System, and State of Alaska Department of Revenue.
View insider buying and selling activity for Fulgent Genetics
or or view top insider-buying stocks.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $70.72.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $1.72 billion and generates $32.53 million in revenue each year. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Fulgent Genetics employs 473 workers across the globe.

What is Fulgent Genetics' official website?

The official website for Fulgent Genetics is www.fulgentgenetics.com.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.